Practical guidance for current and former ODT users If you previously used tirzepatide ODT and need to transition to another option, or if you are currently evaluating alternatives, this section provides actionable next steps
Cost Considerations Cost affects treatment access and sustainability: Brand-name options: Ozempic (for diabetes): $349/month through NovoCare cash-pay Wegovy (for weight management): $349/month through NovoCare cash-pay Compounded semaglutide: $199/month through TrimRx, containing the same active ingredient at lower cost
The flow diagram of literature retrieval is displayed in Figure 1
The general consensus is that any increased risk of retinopathy with GLP-1 RA treatment is likely to be related to the abrupt improvement in glycemic control [108], a phenomenon similar to that reported for other neuropathological complications [109]
The site claimed the product, STDEI GLP-1 Weight Loss Oral Liquid, was made in Australia and developed by a local, family-owned company, even though it is readily available elsewhere on the internet including on AliExpress, eBay and an array of other ghost stores
In more extreme cases, this can result in dehydration